Ludvig Petersson

Ludvig Petersson is affiliated with the Department of Laboratory Medicine at Karolinska Institutet, specifically within the Division of Clinical Pharmacology, and maintains an active institutional presence at Karolinska University Hospital in Stockholm. His work is anchored in pharmacological research with clinical and translational applications.

His primary research domains encompass Pharmacology and Toxicology, with specialized focus on Clinical Pharmacology for elderly populations, Angiogenesis, and Vascular Biology. Key investigations include pharmacological risk assessment in polypharmacy among older adults and biomechanical regulation of blood vessel development, reflecting a blend of clinical epidemiology and molecular mechanisms.

Publication analysis reveals a dual trajectory: clinically oriented studies on drug safety in geriatric care (e.g., Janusmed Risk Profile applications) and foundational vascular research exploring neovascularization and tumor angiogenesis. Methodologies span register-based cross-sectional studies, in vivo assays, and molecular profiling.

No scientific awards are documented in the source material. Dr. Petersson's profile lists no formal advisees or grant details, and there is no mention of laboratory leadership or team affiliations beyond his departmental role.